杂志简称：clin exp med
中文译名：《临床与实验医学》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：18.20%
投稿方向：医学、medicine, research & experimental医学、研究与实验
SCI/E期刊基本信息
出版周期：季刊 地区：意大利
中科院分区：3区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 1591-8890；EISSN 1591-9528
杂志语言：英语
出版国家：意大利
杂志官网 联系方式
出版地址：VIA DECEMBRIO,28,MILAN,ITALY,20137
杂志邮箱：
投稿网址：https://www.editorialmanager.com/clem/
杂志官方网址：https://www.springer.com/journal/10238
出版商网址：
杂志投稿要求
期刊相关咨询邮箱【杂志社官方网站信息】
Contact the journal
Submission-related enquiries
Queries about submission issues, peer review process, or the status of your manuscript should be sent to Anitha Nivas (anitha.nivas@springernature.com).
Production-related enquiries
Queries about accepted manuscripts in production or post-publication corrections should be sent to Anburaj Sundaram (Anburaj.Sundaram@springer.com).
Rights and Permissions enquiries
For permission requests to reuse or reprint content, please follow the link ‘Rights and permissions’ on the relevant article page. For other queries, contact journalpermissions@springernature.com.
Publication-related enquiries
Queries related to journal publishing should be sent to Suzuki Limbu (suzuki.limbu@biomedcentral.com).
投稿须知【杂志社官方网站信息】
Clinical and Experimental Medicine
Submission guidelines
Instructions for Authors
Types of Papers
The journal Clinical and Experimental Medicine publishes reports of clinical and experimental work concerned with the following fields:
clinical chemistry,
hematology,
immunology,
oncology and
virology.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Please minimize the use of abbreviations in the title.
ORCID ID
This publication requires that the corresponding author provides his/her ORCiD ID before proceeding with submission.
For more information about this journal’s ORCiD policy, please visit the ORCID FAQ
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
The name(s) of the author(s)
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Abstract
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
For life science journals only (when applicable)
Trial registration number and date of registration for prospectively registered trials
Trial registration number and date of registration, followed by “retrospectively registered”, for retrospectively registered trials
Keywords
Please provide 4 to 6 keywords which can be used for indexing purposes.